a developer of novel therapies for the treatment of retinal disease
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RRGRX | 7.30 | 0.02 | +0.27% |
DWS RREEF Global Real Estate Secc R6 | |||
IUERX | 24.72 | -0.20 | -0.80% |
JPMorgan International Focus R2 | |||
LVAQX | 20.06 | -0.18 | -0.89% |
LSV Small Cap Value Investor | |||
OIGAX | 35.91 | -0.44 | -1.21% |
Invesco Oppenheimer International Gr A | |||
CGLIX | 17.40 | -0.24 | -1.36% |
Calvert Global Equity Fund Class I |
A.I.dvisor indicates that over the last year, KOD has been loosely correlated with CRSP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then CRSP could also see price increases.
Ticker / NAME | Correlation To KOD | 1D Price Change % | ||
---|---|---|---|---|
KOD | 100% | +4.34% | ||
CRSP - KOD | 44% Loosely correlated | +0.85% | ||
ABCL - KOD | 42% Loosely correlated | -3.99% | ||
RXRX - KOD | 42% Loosely correlated | -10.64% | ||
MGTX - KOD | 41% Loosely correlated | -2.41% | ||
AVIR - KOD | 41% Loosely correlated | -2.72% | ||
More |